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Results: Among chronically stressed women only, greater HPF consumption was associated with
greater abdominal adiposity, oxidative stress, and insulin resistance at baseline (all p’s  .01).
Furthermore, plasma NPY was significantly elevated in chronically stressed women ( p < .01), and
the association of HPF with abdominal adiposity was stronger among women with high versus low
NPY. There were no significant predictions of change over 1-year, likely due to high stability (little
change) in the primary outcomes over this period.
Discussion: Chronic stress is associated with enhanced vulnerability to diet-related metabolic risk
(abdominal adiposity, insulin resistance, and oxidative stress). Stress-induced peripheral NPY may
play a mechanistic role.
# 2014 Published by Elsevier Ltd.
Stress augments diet-related metabolic risk 151. Introduction
Metabolic syndrome has reached epidemic proportions,
affecting 20—30% of adults worldwide (Grundy, 2008). The
implications for the future burden of chronic disease are
grave, as metabolic syndrome doubles the risk of cardiovas-
cular disease and increases the risk for type 2 diabetes by
five-fold (Grundy, 2008). Although metabolic syndrome is
defined as a cluster of medical conditions, abdominal adip-
osity and insulin resistance are core features, even among
those of normal weight (Abbasi et al., 2004; Voulgari et al.,
2011). Chronic psychological stress is an emerging risk factor
that prospectively predicts metabolic syndrome (Pyykkonen
et al., 2010), abdominal fat (Marniemi et al., 2002), and
obesity (Brunner et al., 2007). Furthermore, stress-reduction
can improve glycemic control in type 2 diabetics (Ismail
et al., 2004). Yet, stress reduction has remained essentially
an afterthought within the Western medical model, repre-
senting a lost opportunity to improve prevention and man-
agement.
Stress may promote overeating and physical inactivity,
thereby contributing to metabolic risk (Epel et al., 2004a). In
addition, there appears to be another important, but under-
explored, physiological pathway. Preclinical studies find that
chronic stress activates peripheral mechanisms within adi-
pose tissue, which augment the adverse effects of sugar and
fat on visceral tissue accumulation (Kuo et al., 2007). In mice
fed a high fat/high sugar diet, those mice exposed to chronic
stress developed visceral adiposity and metabolic syndrome
at a considerably faster rate than their non-stressed counter-
parts (Kuo et al., 2007). A key biological mechanism for this
synergistic interaction is the peripheral action of neuropep-
tide Y (NPY), released from sympathetic nerve terminals
innervating visceral adipose tissue, which stimulates adipo-
cyte growth and rapid expansion of visceral fat mass in
response to stress (Kuo et al., 2007).
Excess intake of fat and sugar leads to oversupply of
energy substrate (Picard and Turnbull, 2013), which increases
the production of reactive oxygen species (ROS) by mitochon-
dria and causes oxidative stress (Anderson et al., 2009). One
rodent study has shown that the combination of chronic stress
and a high fat/high sugar diet led to greater oxidative
stress markers of fatty liver disease (Fu et al., 2010). Ele-
vated markers of oxidative stress are associated with human
obesity (Keaney et al., 2003), diabetes (Keaney et al., 2003),
and cardiovascular mortality (Roest et al., 2008). Further,8-hydroxyguanosine (8-oxoG), a marker of RNA oxidation,
prospectively predicts long-term mortality among patients
with diabetes (Broedbaek et al., 2011). Chronic psychological
stress (e.g., caring for a spouse with dementia) has also been
associated with heightened levels of both 8-oxoG and the
oxidative byproduct F2-Isoprostanes (Epel et al., 2004b;
Aschbacher et al., 2013). In turn, oxidative stress can induce
insulin resistance (Ceriello and Motz, 2004; Hoehn et al.,
2009), fomenting the development of metabolic syndrome
(Bremer et al., 2012). However, as yet, no study has assessed
the synergistic effects of psychological stress and diet on
oxidative stress, insulin resistance and adiposity in humans.
The current study utilized a dementia caregiving model of
chronic stress exposure among post-menopausal women and
age-matched, non-caregiving low-stress control women in a
case-control design. We hypothesized that the synergistic
combination of exposure to chronic stress (defined as being a
caregiver) and greater highly palatable food (HPF) consump-
tion would be associated with significantly higher waistline
circumference and truncal fat (abdominal adiposity), mar-
kers of oxidative damage and insulin resistance. These rela-
tionships were examined both cross-sectionally at baseline
and prospectively over 1 year. In addition, we hypothesized
that the chronic stress group would have higher NPY levels
relative to low-stress controls, supporting the peripheral
mechanism of sympathetic innervation of adipocytes estab-
lished in rodent models.
2. Methods
2.1. Participants
Sixty-three non-smoking, post-menopausal women partici-
pated in a larger study of chronic stress, metabolism, and
cellular aging, as described previously (Epel et al., 2010).
Women 50—80 years old were recruited from within the
larger San Francisco Bay area using flyers, and community
advertisements in newspapers, online and on radio stations.
Data for HPF were not available for two women, precluding
their inclusion in this investigation. Of the remaining 61
women, the chronic stress group (CS) consisted of 33 women
providing care for a spouse or parent with dementia (average
years of care = 4.7; range: 0.5—16.5 years). Antidepressant
use was permitted among CS women, because excluding it
would have biased the sample toward highly resilient indi-
viduals, whereas the overarching study sought to understand
16 K. Aschbacher et al.both the mental and physical effects of chronic stress (e.g.,
previous publications in this sample have explored the pro-
spective relations between CS and depressive symptoms
(Aschbacher et al., 2012)). The low stress group (LS) con-
sisted of 28 women of similar age (within a 4-year range) who
were not caregiving, who scored below the national mean on
a well-validated measure of chronic stress, the 10-item
Perceived Stress Scale (PSS < 17) (Cohen and Janicki-
Deverts, 2012), and were not taking antidepressants. Table
1 provides group comparisons on eligibility PSS scores, demo-
graphics, and other relevant health factors. General study
exclusion criteria included chronic medical conditions (car-
diovascular disease, cancer, diabetes, and autoimmune dis-
eases), current smoking, or use of medications known to
affect stress-responsive biomarkers. The mean age was 62
years (range: 51—79), the median income was $70,000—
79,000, and 66% of participants had completed a Bachelor’s
or advance degree. The sample was 80% Caucasian, 3%
African American, 2% Latina/Hispanic, 10% Asian/Pacific
Islander, 2% other, and 3% declined to answer. The study
protocol was approved by the Committee for Human
Research of the University of California, San Francisco.
2.2. Highly palatable food (HPF)
Self-reported dietary consumption was assessed at baseline
using a modified version of the previously published 29-item
version of the Block Food Frequency Questionnaire (FFQ)
(Groesz et al., 2012). The 29-item FFQ is an abbreviated
version of the 100-item FFQ, which has been validated
against nutrient consumption (Block et al., 1990). HPF was
assessed using a four-item subscale, inquiring about theTable 1 Group mean comparisons on demographics, psychosocia
Chronic stress 
Demographic characteristics
Age, yearsa 62 (7) 
Non-Caucasian ethnicityb 6 (19%) 
College or higher educationb 20 (63%) 
Below median incomeb 15 (50%) 
Lifestyle/health factors
Perceived stress scalea 20.27 (5.71) 
Highly palatable fooda 1.42 (0.75) 
Low physical activityb 22 (69%) 
NSAIDsb 14 (44%) 
Cardiometabolic risk
Body mass indexa 26.35 (4.93) 
Triglyceridesa 99.67 (42.36) 
HDLa 66.87 (19.66) 
LDLa 117.71 (29.90) 
Fasting glucose (mg/dl) a 94.34 (8.82) 
Systolic blood pressurea 133.58 (18.81) 
Diastolic blood pressurea 77.12 (8.70) 
Critical alpha = .05. FET = Fisher’s exact test, 2-sided. College or higher 
advanced educational degree.
a Mean (SD).
b n (%).
* p  .05.frequency of similarly categorized foods — e.g., chocolate,
candy bars, cakes, cookies and brownies, etcetera. The
response options ask ‘‘how often’’ a food item was consumed
and response categories range from ‘‘never’’ (0) to ‘‘more
than once a day’’ (5). The scale is deemed appropriate for
comparing relative individual differences in HPF consump-
tion, but not absolute caloric intake.
2.3. Blood draw procedure
Between 0730 and 0800 h, participants came into the Clinical
Research Center at University of California San Francisco. A
venous forearm catheter was inserted, participants rested
for 20 min, and a fasting blood sample was drawn, which was
assayed for peripheral NPY and oxidative stress measures.
2.4. Adiposity measures
Dual-energy X-ray absorptiometry (DXA), a gold-standard
method for assessing abdominal fat depots, was used to
assess truncal fat (kg). Truncal fat and leg fat have been
shown to have opposite relations with fasting and post-load
glucose, suggesting differences in the underlying fat tissue
(Snijder et al., 2004); therefore, we focused on truncal fat,
which is most likely to contribute to or correlate positively
with insulin resistance. Subjects underwent whole-body DXA
scans on a Lunar Prodigy densitometer. Post hoc manual
analysis of fat in the arms, legs, and trunk was performed
using skeletal and soft-tissue landmarks, as first described by
Lo et al. (1998). The trunk region was defined by an upper
horizontal border at the lower edge of the chin, lateral
borders formed by vertical lines which bisected each axillal factors, and metabolic risk.
Low stress Statistical test p-Value
62 (6) t(59) = 0.50 .62
4 (15%) FET .74
19 (70%) x2(1) = 0.41 .53
14 (54%) x2(1) = 0.08 .77
5.30 (3.84) t(53.15) = 11.56 .001 *
1.39 (0.65) t(59) = 0.16 .87
11 (41%) x2(1) = 4.66 .03 *
4 (15%) FET .02 *
26.29 (5.33) t(59) = 0.50 .96
102.96 (41.98) t(57) = 0.30 .77
65.29 (15.92) t(57) = 0.34 .74
106.61 (35.40) t(57) = 1.30 .20
97.43 (10.50) t(58) = 1.24 .22
131.25 (19.07) t(56) = 0.47 .64
75.82 (11.37) t(56) = 0.49 .63
education was categorized as participants holding a Bachelor’s or an
1 One point for IS at baseline and one for IS at 1 year with respec-
tive z-scores of 4.3 and 4.7 were winsorized. One point for NPY with a
z-score of 4.1 was winsorized. We additionally confirmed that re-
gression analyses of the full model using the raw IS outcomes and all
covariates (as specified in Table 3) did not change the pattern of
significance. Winsorizing was not necessary to obtain the reported
results, merely desirable because conclusions from regression are
less subject to potential bias by extreme points.
Stress augments diet-related metabolic risk 17and which were oriented obliquely to include the waist, hip,
buttock and thigh tissue, and a lower border formed by the
intersection of oblique lines extending from the level of the
superior aspect of the iliac crest and passing through the hip
joint. The coefficients of variation for repeated analyses of
the same scans are 0.8, and 1.3% for total and trunk fat,
respectively. For comparison, we also included a simpler
measure that can be easily integrated into large studies:
waistline circumference (cm) at the narrowest point, which
was measured twice by trained research assistants and
averaged.
2.5. Neuropeptide Y (NPY) assay
NPY levels in plasma obtained from peripheral blood were
measured by ELISA (EMD Millipore, St. Charles MO). This assay
is a Sandwich ELISA based on: (1) capture of NPY in the sample
by anti-human NPY IgG and immobilization of the resulting
complex to the wells of a microtiter plate coated by a pre-
titered amount of anchor antibodies, (2) binding of a second
biotinylated antibody to NPY after brief washings, (3) wash
away of unbound materials, followed by conjugation of
horseradish peroxidase to the immobilized biotinylated anti-
bodies, (4) wash away of free enzyme, and (5) quantification
of immobilized antibody-enzyme conjugates by monitoring
horseradish peroxidase activities in the presence of the
substrate 3,30,5,50-tetra-methylbenzidine. The enzyme
activity is measured spectrophotometrically at 450 nm,
and corrected from the absorbency at 590 nm after acidifica-
tion of formed products. Since the increase in absorbency is
directly proportional to the amount of captured NPY in the
unknown sample, the concentration of NPY is derived by
interpolation from a reference curve generated in the same
assay with reference standards of known concentrations of
human NPY. The intra-assay and inter-assay coefficients of
variation were 5 and 14% respectively.
2.6. Oxidative damage assays
Blood serum from fasting blood samples were assayed for 8-
hydroxyguanosine (8-OxoG) and 8-iso-prostaglandin F2a
(IsoP) using the API 4000TM QTRAP1 LC/MS/MS System (Kro-
nos Science Laboratory) per a previously published protocol
(Aschbacher et al., 2013). Serum samples were combined
with an internal standard of either O18-8-hydroxy-20-deoxy-
guanosine (for 8-OxoG) or 8-isoprostaglandin F2a-d4 (for IsoP)
and an organic solvent was added to precipitate proteins. 8-
OxoG (ng/mL) and IsoP (ng/mL) were quantified using the ion
pairs of m/z 300/168 and 353/193 (respectively) investigated
under multiple reaction-monitoring (MRM) detection mode.
The coefficients of variation for ranged from 4 to 8% (intra)
and 8 to 12% (inter) for 8-OxoG and from 4 to 7% (intra) and 6
to 11% (inter) for IsoP.
2.7. Insulin sensitivity
Participants underwent a 3-h oral glucose tolerance test
(OGTT), conducted immediately following the fasting blood
draw, and the composite insulin sensitivity index was deter-
mined from multiple glucose and insulin measures taken over
this 3-h period, per the following standard formula: 10,000/H[(fasting glucose  fasting insulin)(mean glucose  mean
insulin)] (Matsuda and DeFronzo, 1999). A higher score indi-
cates higher insulin sensitivity.
2.8. Health factors
Participants reported whether they had previously been
diagnosed by a physician with any of the following health
conditions relevant to metabolic syndrome and cellular
aging: hypertension, high blood cholesterol, arthritis/
osteoarthritis, or chronic pain. Participants reported use of
medications such as non-steroidal anti-inflammatory medi-
cations (NSAIDs), statins, antidepressants, and vitamin sup-
plements that might contain anti-oxidants. Using a previously
published method (Puterman et al., 2011), we assessed
participants’ self-reports of whether they were sedentary
or active, based on the Center for Disease Control’s recom-
mendations of 75 min of vigorous activity per week.
2.9. Data analysis
Variable distributions were inspected graphically, and a few
outliers were winsorized to 2.6 SD to prevent biasing of the
regression results.1 The primary hypotheses were tested with
regression, in which the main effect of HPF was z-scored so
the corresponding coefficient would reflect the change in the
outcome attributable to a one-standard deviation change in
HPF. The interaction term represented the product of the
standardized HPF score by Group. Two-tailed p-values and a
critical alpha of .05 were used as the criteria for statistical
significance. Longitudinal analyses were conducted by first
examining predictions of the year 1 outcomes, uncorrected
for baseline, and then examining predictions of delta change
variables (e.g., outcome at year 1 — outcome at baseline).
Age was used as a covariate in all analyses, as was antide-
pressant use (an exclusion criteria for the LS), and other
demographic, health or medical factors that significantly
different between the groups were additionally included
as covariates in all full model analyses (see results). All final
model analyses (i.e., the group by HPF interaction regression
models including covariates presented in Table 3) were boot-
strapped using residual resampling with 1000 iterations and
bias-corrected confidence intervals using Matlab R2013b for
Macintosh, which enhances the accuracy of these estimates.
The following variables were missing data at baseline (num-
ber of participants missing data in parentheses) — waist
circumference (4), truncal fat (1), insulin sensitivity (5), 8-
OxoG (2), IsoP (2), and NPY (4). The following variables were
missing data at year 1 — waist circumference (7), truncal fat
(6), insulin sensitivity (7), IsoP (9), and 8-OxoG (20; 8-OxoG
18 K. Aschbacher et al.was analyzed in a subset of the full sample at year 1).
Analyses have varied ‘n’ dependent on the outcome.
3. Results
3.1. Group differences on demographics,
psychological factors and cardiometabolic risk
T-tests or Chi-Squared tests were used to compare the
chronic stress group (CS) and low stress group (LS) on demo-
graphics, psychological factors, and cardiometabolic risk
profiles at the study onset (Table 1). As per the inclusion
criteria, the CS group self-reported significantly higher levels
of chronic stress on the PSS than did the LS group (Table 1).
The mean hours of care provided per day by the CS group was
13.6 h (range: 1—24, mode: 24), and all LS women, by
definition, provided 0 h of care. The CS group endorsed
significantly lower physical activity, and was more likely to
take NSAIDS (Table 1). Hence, the final statistical model
controlled for the following covariates: age, antidepressant
use, NSAID use, and reduced levels of physical activity. The CS
and LS groups were compared on the mean levels of the
primary metabolic outcomes at baseline and one year later,
and significantly differed only on basal 8-OxoG, which, as
previously reported (Aschbacher et al., 2013), was signifi-
cantly higher among the CS group ( p < .01; Table 2). Waist-
line circumference, truncal fat and insulin sensitivity
exhibited high stability over 1 year (.78 < r’s < 97), indicat-
ing that little change occurred on these outcomes from
baseline through year 1.
3.2. Synergistic effects of chronic stress and
consumption of highly palatable food
The primary hypothesis that chronic stress increases vulner-
ability to diet-related metabolic risk was investigated with
bias-corrected bootstrapped regression tests of each group-
by-HPF interaction term on all five outcomes (waistlineTable 2 Group mean differences on metabolic risk indices.
Chronic stress 
Baseline
Waistline circumference (cm) 86.91 (12.78) 
Dex trunk fat (kg) 14.45 (6.09) 
Insulin sensitivity (composite) 4.35 (2.72) 
8-oxoG (ng/mL) 0.04 (0.01) 
F2-Isoprotanes (ng/mL) 0.05 (0.02) 
1 Year
Waistline circumference (cm) 87.17 (13.50) 
Dex trunk fat (kg) 14.26 (6.38) 
Insulin sensitivity (composite) 4.63 (3.20) 
8-oxoG (ng/mL) 0.05 (0.03) 
F2-Isoprotanes (ng/mL) 0.04 (0.02) 
Critical alpha = .05. Means and standard deviations given in table. FET
a Unequal variance assumed per significant Levine’s test.
** p  .01.circumference, truncal fat, insulin sensitivity, 8-OxoG, and
IsoP) at baseline, 1-year, and the longitudinal change terms.
In addition, we investigated the HPF main effect for each
group (chronic versus low stress) to indicate the direction and
magnitude of the association, and to investigate the pattern
across outcomes, even when the interaction might be of
borderline significance in this relatively small sample. Chron-
ological age, NSAIDs, antidepressants, and exercise were
included as covariates in all analyses (rationale described
above). The group by HPF interaction effects were significant
for insulin sensitivity at baseline and year 1, and for 8-OxoG
at baseline (Table 3 and Figs. 1 and 2). The stability coeffi-
cients for waistline circumference, truncal fat, and insulin
sensitivity were high (all r’s > 0.78; Table 3), which indicates
that very little change from baseline occurred. Indeed, the
full model did not predict significant change over 1-year for
any outcome. Simple effect analyses were conducted to
additionally examine the association of HPF with all out-
comes separately in the CS and LS groups. Among the CS
group at baseline, HPF was significantly associated with all
outcomes in the expected direction (all p’s  .05; Table 3),
whereas no significant relationships were present among the
LS group. This pattern persisted at year 1, with similar effect
sizes, smaller samples, and decreased significance.
3.3. Investigation of potential explanatory
factors
We investigated several non-exclusive pathways that might
explain why chronic stress was associated with greater diet-
related metabolic risk: (1) stress promotes heightened con-
sumption of HPF, and/or (2) stress alters peripheral stress-
arousal physiology, which augments adipocyte responses to
HPF. As a group, the CS did not report significantly more HPF
consumption than the LS ( p = .87; Table 1). However, provid-
ing more hours of care per day (an objective index of burden)
was associated with significantly greater HPF consumption
among the CS (Spearman’s rho: r = .40, p = .03).Low stress Statistical comparison
t(df) p-Value
86.63 (12.77) 0.09 (55) .93
14.37 (5.95) 0.05 (58) .96
4.49 (2.12) 0.21 (54) .83
0.02 (0.01) 3.31 (57) <.01 **
0.04 (0.02) 0.66 (55) .51
84.56 (12.17) 0.74 (52) .46
13.95 (6.34) 0.18 (53) .86
4.64 (2.15) 0.02 (52) .99
0.03 (0.02) 1.64 (36.67a) .11
0.04 (0.02) 0.67 (50) .51
 = Fisher’s exact test, 2-sided.
Table 3 Multivariate associations between highly palatable food consumption and metabolic outcomes by group.
Outcome Chronic stress (CS) Low stress (LS) Group*HPF interaction
Unstandardized
coefficient
95% CI Unstandardized
coefficient
95% CI Unstandardized
coefficient
95% CI
Basal waistline
circumference (WC)
5.22 ** (1.47, 8.73) 0.24 (5.34, 4.40) 5.50 *** (12.03, 0.04)
1 Year WC 4.89 * (0.82, 9.23) 1.89 (7.24, 3.59) 6.86 * (13.74, 0.36)
Change in WC from
baseline to 1 year
0.40 (1.03, 1.75) 1.14 (2.81, 0.70) 1.54 (3.64, 0.63)
Basal trunk fat (TF), kg 2.54 ** (0.58, 4.21) 0.07 (2.12, 2.08) 2.44 *** (5.07, 0.61)
1 Year TF 2.26 * (0.27, 4.61) 0.92 (3.50, 2.17) 3.12 *** (6.54, 0.07)
Change in TF from
baseline to 1 year
0.25 (0.81, 0.26) 0.85 * (1.51, 0.21) 0.59 (1.42, 0.21)
Basal insulin
sensitivity (IS)
1.21 ** (1.95, 0.44) 0.43 (0.47, 1.41) 1.66 ** (0.49, 2.88)
1 Year IS 1.16 ** (1.90, 0.44) 0.60 (0.35, 1.64) 1.78 ** (0.56, 2.98)
Change in IS from
baseline to 1 year
0.52 (0.26, 1.23) 0.22 (0.70, 1.20) 0.30 (1.58, 0.91)
Basal 8-hydroxyguanosine
(8-OxoG)
0.007 ** (0.004, 0.012) 0.001 (0.005, 0.004) 0.008 ** (0.014, 0.002)
1 Year 8-OxoG 0.003 (0.009, 0.013) 0.005 (0.009, 0.019) 0.003 (0.015, 0.019)
Change in 8-OxoG from
baseline to 1 year
0.004 (0.015, 0.009) 0.008 (0.006, 0.024) 0.011 (0.007, 0.031)
Basal F2-isoprostanes (IsoP) 0.010 * (0.004, 0.017) 0.005 (0.002, 0.013) 0.005 (0.015, 0.006)
1 Year IsoP 0.005 *** (0.001, 0.011) 0.001 (0.007, 0.007) 0.004 (0.013, 0.004)
Change in IsoP from
baseline to 1 year
0.005 (0.012, 0.002) 0.001 (0.010, 0.007) 0.004 (0.008, 0.014)
All models were adjusted for age, antidepressant use, NSAID use and exercise. All statistical estimates provided herein are based on
bootstrapping using residual resampling with 1000 iterations and bias-corrected confidence intervals. Change outcomes were calculated
using delta scores. The interaction term was formed by calculating the product of caregiver status and the standardized variable for highly
palatable food (HPF).
* p  .05.
** p  .01.
*** p  .10.
Stress augments diet-related metabolic risk 19We analyzed whether, in humans, as in rodents (Kuo et al.,
2007), peripheral NPY might be a mechanism that could
explain how chronic stress enhances vulnerability to diet-
related adiposity. Consistent with this hypothesis, the CS
group had significantly higher levels of basal NPY relative
to the LS group ( p = .001; Fig. 3).Fig. 1 Synergistic effects of chronic stress and highly palatable foo
sake of data visualization, p-values given here are derived from t-test
adjusted for the covariates, which provide the more appropriate, finFurther, we reasoned that if NPY is one of the key stress-
arousal mechanisms contributing to the accumulation of fat
in the CS group, then the strength of the association between
HPF and indices of abdominal adiposity should be greatest
among women with high NPY levels. This hypothesis was
tested by assessing the HPF by NPY interaction, which wasd on waistline circumference. **p  .01, *p  .05. Note: For the
s; however, Table 3 provides bootstrapped regression coefficients
al statistical tests of synergistic (interaction) and main effects.
Fig. 2 Synergistic effects of chronic stress and highly palatable food on oxidative stress and insulin sensitivity. **p  .01, *p  .05.
Note: For the sake of data visualization, p-values given here are derived from t-tests; however, Table 3 provides bootstrapped
regression coefficients adjusted for the covariates, which provide the more appropriate, final statistical tests of synergistic
(interaction) and main effects.
Fig. 3 Peripheral neuropeptide Y (NPY) is elevated under
chronic stress. **p  .01. Mean + SEM depicted. An independent
t-test using a critical alpha of .05 was conducted to obtain the p-
value for the group comparison.
20 K. Aschbacher et al.significantly associated with basal waistline circumference
( p = .02), truncal fat ( p = .01; supplementary figure), and
insulin sensitivity ( p = .04), but not 8-OxoG ( p = .40), or IsoP
( p = .12), while controlling for age, physical activity, NSAIDs
and antidepressant use (as in previous final models).
Supplementary figure related to this article can be found,
in the online version, at http://dx.doi.org/10.1016/j.psy-
neuen.2014.04.003.
4. Discussion
Traditionally, the maintenance of body weight is thought to
be determined by the balance of food intake and expendi-
ture. However, psychological stress has been associated with
both weight gain and weight loss (Nyberg et al., 2012), and
may therefore alter energy homeostasis. There is a missing
link in the current understanding of how and when stress
contributes to obesity and metabolic dysfunction. In animal
studies, when stress becomes chronic (defined by duration
and intensity), sympathetic nerve activity upregulates per-
ipheral expression of NPY, which promotes diet-induced
abdominal adiposity and metabolic dysregulation (Kuo
et al., 2007). Our data are the first to demonstrate in humans
that the synergistic combination of chronic stress along with
consuming more high fat/high sugar foods was associated
with significantly worse metabolic outcomes and greaterwaist circumference. This study underscores the importance
of chronic stress as a modifier of peripheral metabolic and
adipose physiology. If confirmed in interventional studies,
these data suggest the possibility that increasing stress-
resilience skills could improve the efficacy of interventions
to treat metabolic syndrome and obesity, at least for patients
with chronically stressful life circumstances.
Our data, collected among a group of post-menopausal
women who are overweight on average, demonstrate that
more frequent HPF consumption (foods high in sugar and fat)
significantly predicted increased waistline, truncal fat, and
insulin resistance, but only among the group of women
exposed to chronic stress. This association was observed both
at the time of initial assessment and 1 year later (unadjusted
for baseline), while statistically controlling for physical activ-
ity and other possible confounders. In addition, at baseline,
the combination of psychological stress and HPF was signifi-
cantly associated with higher basal levels of 8-OxoG, a
marker of oxidative damage to the genome that predicts
long-term mortality among patients with type 2 diabetes
(Broedbaek et al., 2011). However, no prediction of changes
in metabolic outcomes over 1-year was found, which may be
due to the high stability of these measures across the study.
One previous rodent study also reported synergistic stress-
HPF effects on oxidative stress markers in the context of fatty
liver disease (Fu et al., 2010). While that study did not show
changes in visceral fat (Fu et al., 2010) in contrast to the
study by Kuo et al. (2007), the diet used was considerably
lower in fat and the chronic stressor model did not involve
social threat, a key factor in human stress hormone reactiv-
ity. Although the stress by HPF synergism (i.e., the interac-
tion term) did not reach statistical significance for every
outcome in this clinical study, there was a highly consistent
pattern whereby HPF consumption significantly predicted all
metabolic markers in the chronically stressed group, con-
trolling for age, physical activity, and medical factors (Table
3). Whereas high HPF consumption and a hypercaloric diet
may lead to obesity regardless of stress, these data suggest
that chronic stress may decrease the threshold of metabolic
resilience, so that even low to moderate levels of HPF
consumption proffer greater risks.
Animal models suggest that one mechanism of action by
which chronic stress exacerbates the adverse metabolic
effects of HPF is via upregulation of stress-induced NPY
secretion from sympathetic nerve terminals innervating
Stress augments diet-related metabolic risk 21visceral adipose tissue (Kuo et al., 2007). In our data, chroni-
cally stressed women had significantly higher levels of plasma
NPY, measured in peripheral blood, compared to low stress
women. Furthermore, HPF consumption was a significantly
better predictor of trunk fat and waistline circumference
among those individuals with high levels of plasma NPY.
Hence, these results are consistent with the animal models
in which chronic stress increased NPY secretion, which in
turn, altered adipose tissue sensitivity to HPF. This raises the
intriguing question of whether reducing psychological stress
or peripheral NPY signaling could potentially help individuals
lose fat more successfully, even if diet and activity levels
remained the same.
This study used a well-accepted and oft-studied human
model of chronic stress, caring for a loved one with dementia,
which has been previously associated with weight gain (Fred-
man and Daly, 1997) and with alterations in a host of cardi-
ometabolic risk markers (Vitaliano et al., 2002; Aschbacher
et al., 2008; Mausbach et al., 2012). As a group, chronically
stressed women did not report greater HPF consumption than
low stress women. However, within the high stress group, the
objective indicator of the degree of chronic stress exposure
(hours of care provided per day) was significantly related to
greater HPF consumption. Future studies should investigate
whether other socially relevant models of chronic stress
(e.g., low socioeconomic status, unemployment, traumatic
stress) moderate the effects of HPF on metabolic risk, as well
as extending these findings to males, children, and other age
groups.
As a limitation, this study used a case-control design, as it
would be unethical to assign humans to chronically stressful
conditions. Self-reports (such as our HPF measure) may be
subject to social desirability and recall biases, and provide
stronger indications of relative than absolute intake. None-
theless, this study represents a critical step needed to justify
considerably more resource-intensive studies involving feed-
ing paradigms, multiple daily dietary assessments, and bio-
markers for macronutrient consumption. Future studies
might randomly assign participants with a range of stress
levels to a feeding study comparing diets with relatively
greater or lesser amounts of sugar/fat, and obtain absolute
measures of overall caloric, macro- and micronutrient
intake. Waistline and truncal fat are proxies but not precise
measures of visceral fat; nonetheless, both visceral and
subcutaneous fat are associated with heightened metabolic
risk (Fox et al., 2007). There are limits to the generalizability
of these findings, given our sample was composed of post-
menopausal women who were predominantly Caucasian.
Menopause is a risk factor for an increase in visceral fat
specifically, as well as total body fat (Lovejoy et al., 2008).
The high stability of metabolic outcomes over 1year in this
sample made it difficult to detect prospective changes in
metabolic risk. Future studies should reexamine prospective
relations in samples with greater longitudinal variability,
over longer periods, or in which an intervention has been
used to experimentally elicit variability.
People under chronic stress are already known to be at
higher risk of metabolic disease, although the mechanisms
underlying this link are unclear. This study illuminates an
important pathway by which stress-induced changes in per-
ipheral physiology increase the likelihood that consuming
HPF will lead to the preferential accumulation of abdominalfat and the worsening of metabolic risk factors. The implica-
tion of this work is that chronically stressed individuals are
more vulnerable to a high fat/high sugar diet. If confirmed,
these data invite the exciting possibility that increasing
resilience skills could improve the efficacy of interventions
to help individuals lose weight and manage metabolic syn-
drome, even if diet and activity levels remained the same.
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